Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | CX-904 |
Trade Name | |
Synonyms | CX 904|CX904|AMG 651|AMG651|AMG-651 |
Drug Descriptions |
CX-904 comprises a bispecific antibody targeting both EGFR and CD3 linked to masking peptide that is cleaved by tumor-specific proteases in the tumor microenvironment, which potentially leads to an enhanced cytotoxic T-lymphocyte (CTL) response against tumor cells expressing EGFR (NCI Drug Dictionary). |
DrugClasses | CD3 Antibody 93 EGFR Antibody 57 |
CAS Registry Number | NA |
NCIT ID | C188057 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CX-904 | CX-904 | 0 | 1 |